What changed 10-K

Item 1A. Risk Factors

2025-04-15 compared with 2024-04-15 · 4 added, 4 removed, 1938 unchanged (0% of the section changed)

393 unchanged sentences

Risks associated with out-licensing transactions of our products in foreign countries include:

to obtain regulatory approval or intellectual property rights in any country which could lead to the termination of a licensing

transaction in that country;

inability to obtain the issuance of patent claims or regulatory status in a foreign country that provide periods of market

exclusivity or data exclusivity prior to the entry of generic or biosimilar forms of our products;

to obtain regulatory approval or intellectual property rights in any country which could lead to the termination of a licensing transaction

in that country;

inability to obtain the issuance of patent claims or regulatory status in a foreign country that provide periods of market exclusivity

or data exclusivity prior to the entry of generic or biosimilar forms of our products;

difficulty of pursuing legal remedies to disputes or to secure monetary damages in foreign countries;

1543 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.